The application for the renewal of the approval of the active substance magnesium phosphide was submitted on 30 August 2016 and the rapporteur Member State informed the co-rapporteur Member State, the Commission and the Authority on 6 October 2016 that it had assessed the admissibility of the application pursuant to Article 3 of Implementing Regulation (EU) No 844/2012, and in particular its completeness and timeliness, and concluded that it was admissible. The application has been made public by the Authority. On 14 April 2023, the rapporteur Member State submitted the draft renewal assessment report to the Authority. The Authority estimates that it will be able to finalise its conclusion for magnesium phosphide by the end of December 2027, and as the Commission will need time to adopt the ensuing risk management decisions, the duration of the extension of the approval period should be set at 26 months, until 31 January 2029.
Recital 33, Regulation (EU) 2026/2348
In force
- celex=32012R0844